Navigation Links
VABC Responds to Study on Use of Cholesterol Lowering Drug Statins on Cancer Patients
Date:12/8/2012

New York, NY (PRWEB) December 08, 2012

On December 8, Voices Against Brain Cancer (VABC) releases a statement in reaction to the results of a new study on taking a cholesterol lowering drug that reduces the death risk in cancer patients.

According to an article on NBC News, “the patients who took statins were about 15 percent less likely to die from their cancer than other cancer patients were, the researchers reported after studying the records of nearly 300,000 people.”

The article affirms that the research is not conclusive since it was only based on studies of past medical records, and further research would be needed to prove that statins do reduce the risk of death in cancer patients. However, according to the article, “studies have shown that by blocking cholesterol production and certain protein interactions in cells, statins may influence the ability of cells to proliferate and migrate through the body. So statins could be reducing the ability of cancer cells to metastasize.”

In reaction to these findings, VABC representative Clay Darrohn stated, “We would definitely like to see more in-depth research of these findings. If conclusive, these studies could be very exciting for further brain cancer research.”

VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, John Hopkins, Memorial Sloan-Kettering and Yale, to name a few.

VABC's mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.

For press inquiries, please contact: 5W Public Relations.
#####

Read the full story at http://www.prweb.com/releases/2012/12/prweb10211128.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Probiotic Action Responds an Article on ‘Skin Care Coaches’
2. Chronic Cough Responds to Epilepsy Drug, Study Finds
3. Transvaginal Mesh Lawsuit Update: New Study Concerning Use of Vaginal Mesh in Prolapse Procedures, Bernstein Liebhard LLP Reports
4. Too Little Sleep Spurs Appetite-Boosting Hormones: Study
5. Funding Meals on Wheels Keeps Seniors Independent: Study
6. Avastin Wont Extend Breast Cancer Survival: Study
7. Vanderbilt study finds diverse genetic alterations in triple-negative breast cancers
8. Kids With Autism Common Users of ERs, Study Says
9. Study compares standard against newer treatment in women whose breast cancer has spread
10. Just Lowering Fat Intake Can Shed Pounds, Study Finds
11. Fasting may benefit patients with epilepsy, Johns Hopkins Childrens Center study suggests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and ... of published author, William Nowers. Captain Nowers and his wife, Millie, have six ... years in the Navy. Following his career as a naval aviator and carrier ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
(Date:10/12/2017)... Wesley Chapel, FL (PRWEB) , ... October 12, 2017 , ... ... Chapel is holding a treadmill relay – Miles by Moonlight to raise money for ... by donating $300 or more. , Teams will work together to keep their ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017 The Rebound mobile app is poised ... reverse the tide of prescription drug addiction. The app empowers ... intake and stepping down their dosage in a safe, controlled ... December 2017; the first 100,000 people to sign up will ... http://www.rebound-solution.com/ ...
(Date:9/27/2017)... -- Commended for their devotion to personalized service, SMP Pharmacy Solutions ... in the South Florida Business Journal,s 50 Fastest-Growing Companies, and ... the national specialty pharmacy has found its niche.  To that ... be honored by SFBJ as the 2017 Power Leader in ... receive his award in October, Bardisa said of the three ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
Breaking Medicine Technology: